ADALIMUMAB ACHIEVES COMPLETE REMISSION AT 52 WEEKS IN JAPANESE PATIENTS WITH INTESTINAL BEHÇET'S DISEASE
Fumihito Hirai 1
Satoshi Tanida 2
Nagamu Inoue 3
Makoto Naganuma 3
Anne Camez 4
Bidan Huang 4
Vipin Arora 4
Morio Ozawa 5
Toshifumi Hibi 6
Roopal B Thakkar 4
1 Fukuoka University Chikushi Hospital
2 Nagoya City University Hospital
3 Keio University School of Medicine
4 AbbVie
5 AbbVie GK
6 Kitasato Institute Hospital
Session
IBD III
Conference
UEG Week 2013
Citation
United European Gastroenterology Journal; 2013: 1 (Supplement 1) A521
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing